[HTML][HTML] Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
M Dema, H Eixarch, LM Villar, X Montalban… - Autoimmunity …, 2021 - Elsevier
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase
in the life expectancy of the general population and the availability of effective disease …
in the life expectancy of the general population and the availability of effective disease …
[PDF][PDF] Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
M Dema, H Eixarch, LM Villar, X Montalban… - Autoimmunity …, 2021 - core.ac.uk
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase
in the life expectancy of the general population and the availability of effective disease …
in the life expectancy of the general population and the availability of effective disease …
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
M Dema, H Eixarch, LM Villar… - Autoimmunity …, 2021 - pubmed.ncbi.nlm.nih.gov
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase
in the life expectancy of the general population and the availability of effective disease …
in the life expectancy of the general population and the availability of effective disease …
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
M Dema, H Eixarch, LM Villar, X Montalban… - Autoimmunity …, 2021 - ddd.uab.cat
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase
in the life expectancy of the general population and the availability of effective disease …
in the life expectancy of the general population and the availability of effective disease …
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets.
M Dema, H Eixarch, LM Villar, X Montalban… - Autoimmunity …, 2021 - europepmc.org
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
M Dema, H Eixarch, LM Villar… - Autoimmunity …, 2021 - portalrecerca.uab.cat
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase
in the life expectancy of the general population and the availability of effective disease …
in the life expectancy of the general population and the availability of effective disease …